FDA alert: Mislabeled pills prompt Cyclobenzaprine recall across US; know the potential risks

A nationwide recall has been initiated by Unichem Pharmaceuticals due to a significant pill mix-up. Certain bottles of Cyclobenzaprine Hydrochloride Tablets, intended as a muscle relaxant, were incorrectly labeled and contained Meloxicam tablets, an anti-inflammatory drug. This poses serious health risks, including heart complications and stomach bleeding, especially for those with pre-existing conditions.